article Open AccessTop 1% cited
Antithrombotic Therapy for Atrial Fibrillation
CHEST Journal · 2012 · Vol. 141(2) · pp. e531S–e575S
John J. You(McMaster University)Daniel E. Singer(Harvard University)Patricia Howard(University of Kansas Medical Center)Deirdre A. Lane(University of Birmingham)Mark H. Eckman(University of Cincinnati)Margaret C. Fang(San Francisco General Hospital)Elaine M. Hylek(Boston University)Sam Schulman(McMaster University)Alan S. Go(Kaiser Permanente)Michael Hughes(Decision Research)Frederick A. Spencer(McMaster University)Warren J. Manning(Beth Israel Deaconess Medical Center)Jonathan L. Halperin(Mount Sinai Medical Center)Gregory Y.H. Lip✉(University of Birmingham)
Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular DiseasesVenous Thromboembolism Diagnosis and ManagementMedicineAntithromboticAspirinClopidogrelAtrial fibrillationStroke (engine)Internal medicineCardiologyThrombosisCombination therapy
MeSH terms
DabigatranClopidogrelAdministration, OralAnticoagulantsAspirinAtrial FibrillationAtrial FlutterBenzimidazolesDose-Response Relationship, DrugDrug Therapy, CombinationElectric CountershockFibrinolytic AgentsHemorrhageHumansRisk Factors
Funding
- Bristol-Myers Squibb
- Sanofi
- National Heart, Lung, and Blood Institute
Citations
918
FWCI
98.29
field-weighted impact
References
186
Percentile
100%
vs. same field & year
Citations per year
Cited by
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Circulation · 2014 · 7,136 citations
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Circulation · 2019 · 2,707 citations
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Stroke · 2014 · 5,167 citations
Antithrombotic Therapy for Atrial Fibrillation
CHEST Journal · 2018 · 924 citations
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
Thrombosis and Haemostasis · 2012 · 489 citations
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Circulation · 2012 · 4,719 citations
Executive Summary
CHEST Journal · 2012 · 1,539 citations
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Journal of the American College of Cardiology · 2012 · 2,608 citations
References
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
New England Journal of Medicine · 2001 · 6,459 citations
Oral Anticoagulant Therapy
CHEST Journal · 2012 · 1,489 citations
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
BMJ · 2002 · 6,935 citations
Validation of Clinical Classification Schemes for Predicting Stroke
JAMA · 2001 · 4,834 citations
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
The American Journal of Medicine · 1998 · 776 citations
Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
Thrombosis and Haemostasis · 2008 · 369 citations
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
New England Journal of Medicine · 2011 · 9,320 citations
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Thrombosis and Haemostasis · 2010 · 1,372 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.